Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:e139
Published online before print September 29, 2008, doi: 10.1161/HYPERTENSIONAHA.108.122192
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/5/e139    most recent
HYPERTENSIONAHA.108.122192v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brien, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O'Brien, E.
Related Collections
Right arrow Clinical Studies
Right arrow Other diagnostic testing

(Hypertension. 2008;52:e139.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Response to Prevalence and Risk Factors of Masked Hypertension Identified by Multiple Self-Blood Pressure Measurement

Eoin O'Brien

Blood Pressure Unit, St Michaels Hospital, Conway Institute of Biomolecular and Biomedical Research, Belfield, Dublin, Ireland

I would like to thank Lee and Park1 for their comments on my review of ambulatory blood pressure measurement (ABPM)2 and for presenting their interesting data on self-blood pressure measurement (SBPM) in >5000 hypertensive patients.

The authors suggest that, whereas ABPM provides a greater amount of information on blood pressure behavior than SBPM, its routine use is limited by its expense and the discomfort of the technique that may limit normal activities. ABPM certainly offers greater information than SBPM, most especially in identifying nocturnal hypertension, dipping, nondipping, and the morning surge, all of which are accepted as factors that may have a profound influence on cardiovascular outcome.2,3

The view expressed by the authors that the expense of ABPM should limit its routine use in clinical practice has been bandied about for years despite the fact that it has been shown that ABPM can result in a potential savings of 3% to 14% for cost of care for hypertension and 10% to 23% reduction in treatment days when the technique is incorporated into the diagnostic process.4 These estimates do not take into account the financial saving of provided by the dabl ABPM program, which generates an interpretative report (thereby dispensing with the time and cost for an expert to report on the data), to which may be added the potential savings inherent in the provision of online analysis of ABPM data.2

The authors also suggest that the "discomfort" of ABPM is an advantage over SBPM. However, to obtain a BP profile that equates to daytime ABPM, it is necessary for daily duplicate morning and evening SBPM measurements on 7 days, with the first day readings being discarded and the remaining measurements averaged.2 So, if we equate "convenience" with discomfort, the 2 methodologies for providing out-of-office BP make distinctly different demands on the patient, and with ABPM there is the added advantage of the nocturnal BP being available for analysis.

In my review, I made the plea that "rather than arguing for one technique over the other, both techniques ... give differing information about BP behavior that may assist in understanding and managing hypertension,"2 and they should be seen, therefore, as complimentary rather than competitive. Indeed, the technology is now available to enable manufacturers to provide us with "a device for all seasons"–an inexpensive monitor financially within the reach of the patient, as well as healthcare professionals, that will be able to record and analyze data in a standardized format according to the clinical requirement for a single BP measurement, repeated BP measurements at home or in the workplace, or BP measurement at predetermined intervals during the day and night over a 24- or 48-hour period.


*    Acknowledgments
 
Disclosures

The author has contributed financially to the development of the dabl ABPM software program and is a member of the Board of dabl Limited (www.dabl.ie).


*    References
up arrowTop
*References
 
1. Lee H-Y, Park JB. Prevalence and risk factors of masked hypertension identified by multiple self-blood pressure measurement. Hypertension. 2008; 52: e137–e138.[Free Full Text]

2. O'Brien E. Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension. 2008; 51: 1435–1441.[Free Full Text]

3. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension. 2005; 46: 156–161.[Abstract/Free Full Text]

4. Krakoff LR. Cost-effectiveness of ambulatory BP: a reanalysis. Hypertension. 2006; 47: 29–34.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/5/e139    most recent
HYPERTENSIONAHA.108.122192v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brien, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O'Brien, E.
Related Collections
Right arrow Clinical Studies
Right arrow Other diagnostic testing